Gene Therapies Unlock New Possibilities for Curing Genetic Diseases

  • Targeted treatment that corrects genetic mutations at the source
  • Successful treatment of inherited retinal diseases, hemophilia, and spinal muscular atrophy
  • Potential to provide lifelong cures for patients with single-gene disorders
Explore Gene Therapies

Gene therapies available through Clinicians International's network are performed in compliance with the regulatory standards of the host country. These therapies may not be FDA-approved for all indications. It is essential for patients to have detailed discussions with their healthcare provider to understand the implications, risks, and benefits of gene therapies. Clinicians International collaborates with internationally recognized clinics to provide safe and effective treatments.

Clinicians International can help

Start your Free Pre-Consultation Now

Results and offers may vary.

Powered by the latest peer-reviewed research and the world’s best gene therapies specialists

has restored functional vision in patients with inherited retinal disease caused by mutations in the RPE65 gene, with sustained improvements observed over several years.

has shown remarkable efficacy in treating spinal muscular atrophy (SMA), with treated infants achieving developmental milestones such as sitting without support, which are rarely seen in untreated patients.

Are you a good candidate for Gene Therapies?

Start your Free Pre-Consultation Now

Specific genetic
mutations

/assets/Explore safe surgery options

Patients with specific genetic mutations that are directly targeted by available gene therapies, such as mutations in the RPE65 gene (inherited retinal disease) or the SMN1 gene (spinal muscular atrophy), are ideal candidates.

Early diagnosis
and treatment

/assets/Explore safe surgery options

Patients diagnosed and treated early in the course of their disease tend to have better outcomes with gene therapy, as early intervention can prevent the progression of debilitating symptoms.

Absence of severe
immune response

/assets/Explore safe surgery options

Patients without a history of severe immune responses or allergies to viral vectors used in gene therapies are better candidates, as they are less likely to experience adverse reactions.

Prelimenary steps before
starting gene therapies

/assets/Free pre-consultation/assets/Free pre-consultation/assets/Free pre-consultation/assets/Free pre-consultation/assets/Free pre-consultation/assets/Free pre-consultation

24/7 access to free pre-consultation

Through Clinicians International, you can take a thorough pre-consultation and get matched with the world’s best gene therapy specialists to help plan the rest of your life pain-free.

How it Works

Frequently asked Questions about gene therapies

Gene therapy is a technique that modifies a person’s genes to treat or prevent disease. This can involve replacing a faulty gene, inactivating a malfunctioning gene, or introducing a new or modified gene into the body to help treat a disease.
Gene therapy can treat a range of conditions, including genetic disorders like cystic fibrosis, certain types of cancer, hemophilia, and some viral infections. Ongoing research is expanding the potential applications of gene therapy.
Risks can include immune reactions, targeting the wrong cells, infection, and the potential development of cancer if the gene insertion disrupts normal cell function. Long-term studies are necessary to fully understand the risks.
Gene therapy can be administered in several ways, including intravenous injection, direct injection into the target tissue, or through cells that have been modified outside the body and then reintroduced (ex vivo therapy).
The effectiveness of gene therapy varies by disease and the specific technique used. For some conditions, like spinal muscular atrophy, gene therapy has shown dramatic improvements. However, long-term efficacy and safety are still being studied.

Hear it from research papers

Four Success Stories:

in Gene Therapy - 2020

This paper highlights four successful cases in gene therapy, including treatments for sickle cell disease, beta thalassemia, and spinal muscular atrophy, using CRISPR-Cas9 and other gene-editing technologies.

Gene Therapy for Cystic Fibrosis:

Progress and Challenges of Genome Editing - 2020

This review discusses advancements in gene therapy for cystic fibrosis, focusing on genome editing techniques like CRISPR-Cas9 and their potential to correct genetic defects in the CFTR gene.

The Promise and the Hope:

of Gene Therapy - 2021

This paper reviews the development and clinical success of gene therapies such as Zynteglo for beta thalassemia, discussing the progress in HSC gene therapy and its impact on genetic diseases.